6 курс / Гастроэнтерология / Марченко_Н_В_Клинико_морфологические_и_психоэмоциональные_взаимосвязи
.pdf221
266.Prince, M. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years / M. Prince, A. Chetwynd, W. Newman // Gastroenterol. — 2002. — Vol. 123, № 4. — P. 1044-1051.
267.Prince, M. I. Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort / M. I. Prince, A. Chetwynd, W. L. Craig [et al.] // Gut. — 2004. — Vol. 53, № 6. — P. 865-870.
268.Qin, B. Effect of the polymorphisms of tumor necrosis factor-α gene on the
susceptibility to primary biliary cirrhosis: a meta-analysis / B. Qin, Y. Liang, Z. Yang, R. Zhong // Eur. J. Gastroenterol. Hepatol. — 2012. — Vol. 24, № 12. — P. 1386-1392.
269.Rappaport, A.M. The microcirculatory hepatic unit / A.M. Rappaport // Microvasc. Res. — 1973. — Vol. 6. — P. 212-228.
270.Rieger, R. The X and why of xenobiotics in primary biliary cirrhosis / R. Rieger, M. E. Gershwin // J. Autoimmun. — 2007. — Vol. 28, № 2-3. — P. 76-84.
271.Rigopoulou, E. I. Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found / E. I. Rigopoulou, D. Roggenbuck, D.S. Smyk [et al.] // Autoimmun. Rev. — 2012. — Vol. 12, № 2. — P. 260–269.
272.Rigopoulou, E. I. Epstein-barr virus as a trigger of autoimmune liver diseases / E. I. Rigopoulou, D. S. Smyk, C. E. Matthews [et al.] // Adv. Virol. — 2012. Режим доступа: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368154/
273.Rizzetto, M. Characterization of the microsomal antigen related to a subclass of active chronic hepatitis / M. Rizzetto, F. B. Bianchi, D. Doniach // Immunology. —
1974. — Vol. 26, № 3. — P. 589-601.
274.Rothe, J. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes / J. Rothe, W. Lesslauer, H. Lotscher [et al.] // Nature. — 1993. — № 364. — P. 798-
275.Rubin, E. Primary biliary cirrhosis: chronic non-suppurative destructive cholangitis / E. Rubin, F. Schaffner, H. Popper // Am. J. Pathol. — 1965. — Vol. 46,
№3. — P. 387-407
222
276.Saitis, A. Use of TNFα antagonists in refractory AIH: revealing the unforeseen / A. Saitis, N. Gatselis, K. Zachou // J. Hepatol. — 2013. — Vol. 59, № 1. — P. 197-198.
277.Sakugawa, H. Epidemiology of primary biliary cirrhosis among women with elevated gamma-glutamyl transpeptidase levels in Okinawa, Japan / H. Sakugawa,
H. Nakasone, T. Nakayoshi [et al.] // Hepatol. Res. — 2003. — Vol. 26, № 4. —
P. 330-336.
278. Saxena, R. Destruction of canals of Hering in primary biliary cirrhosis / R. Saxena, P. Hytiroglou, S. N. Thung, N. D. Theise // Hum. Pathol. — 2002. — Vol. 33,
№ 10. — P. 983-988.
279.Scheuer, P. J. Classification of chronic viral hepatitis: a need for reassessment / P. J. Scheuer // J. Hepatol. — 1991. — Vol. 13, № 3. — P. 372-374.
280.Sebagh, M. Histologic Findings Predictive of a Diagnosis of De novo Autoimmune Hepatitis After Liver Transplantation in Adults [Электронный ресурс] / M. Sebagh, M. Castillo-Rama, D. Azoulay [et al.] // Transplantation. — 2013. Режим доступа: http://www.medicaltraining.hu/index.php?page=dlist&wht=34544
281.Sedgwick, J. D.Tumor necrosis factora master-regulator of leukocyte movement / J.D. Sedgwick, D.S. Riminton, J.G. Cyster, H. Korner // Immunol. Today. – 2000. –№
21. – P. 110–113.
282.Selmi, C. Infectious agents and xenobiotics in the etiology of primary biliary cirrhosis / C. Selmi, M. De Santis F. Cavaciocchi, E. M. Gershwin // Curr. Opin. Rheumatol. — 2010. — Vol. 29, № 6 — P. 287–299.
283.Selmi, C. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment / C. Selmi, M. J. Mayo, N. Bach [et al.] // Gastroenterol. — 2004. — Vol. 127, № 2. — P. 485–492.
284.Senaldi, G. Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis / G. Senaldi, B. Portmann, A. P. Mowat [et al.] // Arch. Dis. Child. — 1992. — Vol. 67, № 12. — P. 1447-1453.
285.Shapiro, J. M. Serum bilirubin: a prognostic factor in primary biliary cirrhosis / J. M. Shapiro, H. Smith, F. Schaffner // Gut. — 1979. — Vol. 20, № 2. — P. 137–140.
223
286.Shimoda, S. CD4 T-cell autoreactivity to the mitochondrial autoantigen PDCE2 in AMA-negative primary biliary cirrhosis / S. Shimoda, H. Miyakawa, M. Nakamura [et al.] // J. Autoimmun. — 2008. — Vol. 31, № 2. — P. 110-115.
287.Singh R. Acute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literature / R. Singh, S. Nair, G. Farr [et al.] // Am. J. Gastroenterol. — 2002. — Vol. 97, № 10. — P. 2670–2673.
288.Sisman, G. Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: the first case in the literature [Электронный доступ] / G. Sisman, Y. Erzin, K. Bal // J. Crohns Colitis. – 2013. –
Vol. 7, № 9. Режим доступа: http://www.ecco-jccjournal.org/
289.Smith, R. S. The macrophage theory of depression / R. S. Smith // Med. Hypotheses. — 1991. — Vol. 35, № 4. — P. 298-306.
290.Smyk, D. S. Urinary tract infection as a risk factor for autoimmune liver disease: from bench to bedside / D. S. Smyk, D. P. Bogdanos, S. Kriese [et al.] // Clin. Res. Hepatol. Gastroenterol. — 2012. — Vol. 36, № 2. — P. 110-121.
291.Smyk, D. PBC triggers in water reservoirs, coal mining areas and waste disposal sites: from Newcastle to New York / D. Smyk, M. G. Mytilinaiou, E. I.
Rigopoulou, D. P. Bogdanos // Dis. Markers. — 2010. — Vol. 29, № 6. — P. 337-344. 292. Smyk, D. S. Familial primary biliary cirrhosis: like mother, like daughter? / D. S. Smyk, E. I. Rigopoulou, A. Pares //Acta. Gastroenterol. Belg. — 2012. — Vol. 75, №
2. — P. 203-209.
293.Sockalingam, S. Identifying opportunities to improve management of
autoimmune hepatitis: evaluation of drug adherence and psychosocial factors / S. Sockalingam, D. Blank, N. Abdelhamid [et al.] // Hepatol. — 2012. — Vol. 57, № 6.
— P. 1299–1304.
294. Sogolow, E. D. Fatigue as a major predictor of quality of life in women with autoimmune liver disease: the case of primary biliary cirrhosis / E. D. Sogolow, J. N. Lasker, L. M. Short // Womens Health Issues. — 2008. — Vol. 18, № 4. — P. 336-342.
224
295. Solís-Herruzo, J. A. The pathogenesis of primary biliary cirrhosis / J. A. SolísHerruzo, P Solís-Muñoz., T. Muñoz Yagüe // Rev. Esp. Enferm. Dig. — 2009. —Vol.
101, № 6. — P. 413-423.
296.Soloway, R. D. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis / R. D. Soloway, W. Summerskill H., A. H. Baggenstoss [et al.] // Gastroenterol. — 1972. —
Vol. 63, № 5. — P. 820–833.
297.Spadaro, A. Effect of tumor necrosis factor alpha antagonists in a patient with rheumatoid arthritis and primary biliary cirrhosis / A. Spadaro, R. Scrivo, V. Riccieri [et al.] // Joint. Bone Spine. — 2008. — Vol. 75, № 1. — P. 87-89.
298.Spierings, D. C. Tissue distribution of the death ligand TRAIL and its receptors / D. C. Spierings, E. G. de Vries, E. Vellenga [et al.] // J. Histochem. Cytochem. —
2004. — Vol. 52, № 6. — P. 821-831.
299.Springer, J. E. Vitamin D-receptor genotypes as independent genetic predictors
of decreased bone mineral density in primary biliary cirrhosis / J. E. Springer, D. E. Cole, L. A. Rubin [et al.] // Gastroenterology. — 2000. — Vol. 118,
№ 1. — P. 145-151.
300.Srivastava, S. Psychological stress is associated with relapse in type 1 autoimmune hepatitis / S. Srivastava, J. L. Boyer / Liver Int. — 2010. — Vol. 30, № 10.
— P. 1439–1447.
301.Streetz, K. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure / K. Streetz, L. Leifeld, D. Grundmann [et al.] // Gastroenterology. — 2000. — Vol. 119, № 2. — P. 446-460.
302.Strassburg, C. P. Autoantibodies and autoantigens in autoimmune hepatitis / C. P. Strassburg, M. P Manns. // Semin. Liver Dis. — 2002. — Vol. 22, № 4. — P. 339–
352.
303.Suzuki, A. The use of liver biopsy evaluation in discrimination of idiopathic
autoimmune hepatitis versus drug-induced liver injury / A. Suzuki, E. M. Brunt, D. E. Kleiner [et al.] // Hepatology. — 2011. — Vol. 54, № 3. — P. 931-939.
225
304. Tabak, F. Autoimmune hepatitis induced by the prolonged hepatitis A virus infection / F. Tabak, F. Ozdemir, O. Tabak // Ann. Hepatol. — 2008. — Vol. 7, № 2. —
P. 177-179.
305. Tacke, F. Inflammatory pathways in liver homeostasis and liver injury / F. Tacke, T. Luedde, C. Trautwein // Clin. Rev. Allergy Immunol. — 2009. — Vol. 36,
№ 1. — P. 4-12.
306.Talwalkar, J. A. Primary biliary cirrhosis / J. A Talwalkar, K. D. Lindor // Lancet. — 2003. — Vol. 362, № 9377. — P. 53–61.
307.Talwalkar, J. A. Natural history of pruritus in primary biliary cirrhosis / J. A. Talwalkar, E. Souto, R. A. Jorgensen, K. D. Lindor // Clin. Gastroenterol. Hepatol. —
2003. — Vol. 1. — P. 297-302.
308.Tanaka, A. The tumor necrosis factor-alfa promoter correlates with rogression
of primary biliary cirrhosis / A. Tanaka, S. Quaranta, A. Mattalia [et al.] // J.
Hepatol. — 1999. — Vol. 30, № 5. — P. 826-829.
309.Tang, J. Association of polymorphisms in non-classic MHC genes with
susceptibility to |
autoimmune |
hepatitis / J. Tang, C. Zhou, Z. J. Zhang, S. S. // |
|
Hepatobiliary Pancreat. Dis. Int. — 2012. — Vol. 11, № 2. — P. 125-131. |
|||
310. |
Terasaki, |
S. Three |
cases of primary biliary cirrhosis associated with |
bronchial asthma / S. Terasaki, Y. Nakanuma, M. Hoso [et al.] // J. Gastroenterol. — 1995. — Vol. 30, № 5. — P. 667-671.
311.Trivedi, P. J. Mucosal immunity in liver autoimmunity: a comprehensive review / P. J. Trivedi, D. H. Adams // J. Autoimmun. — 2013. — Vol. 46. — P. 97-111.
312.Trivedi, P.J. Review article: overlap syndromes and autoimmune liver disease / P.J. Trivedi, G.M. Hirschfield // Aliment. Pharmacol. Ther. — 2012. — Vol. 36. —
P. 517-33.
313. Trzepacz, P. A psychiatric study of 247 liver transplantation candidates / P. Trzepacz, R. Brenner, D. Van Thiel // Psychosomatics. — 1989. — Vol. 30, № 2. —
P. 147-153.
226
314.Twaddell, W. S. Evolution from primary biliary cirrhosis to primary biliary cirrhosis/autoimmune hepatitis overlap syndrome / W. S. Twaddell, J. Lefkowitch, P. D. Berk // Semin. Liver Dis. — 2008. — Vol. 28, № 1. — P. 128-134.
315.Umekita, K. Improvement of rheumatoid arthritis and autoimmune hepatitis in a patient treated with the tumor necrosis factor inhibitor, etanercept / K. Umekita, S. Miyauchi, S. Ueno [et al.] // Intern Med. — 2011. — Vol. 50, № 11. — P. 1245-1249.
316.Van Norstrand, M. D. Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression / M. D. Van Norstrand, M. Malinchoc, K. D. Lindor [et al.] // Hepatol. — 1997. — Vol. 25, № 1. —
P. 6-11.
317.Van Os, E. Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis / E. Van Os, W. W. van den Broek, P. G. Mulder [et al.] // J. Hepatol. — 2007. — Vol. 46, № 6. — P. 1099-1103.
318.Varyani, F. K. Primary biliary cirrhosis does not increase the risk of UTIs
following diagnosis compared to other chronic liver diseases? / F. K. Varyani, J. West, T. R. Card // Liver Int. — 2013. — Vol. 33, № 3. — P. 384-388.
319. Vento, S. Epstein-Barr virus a trigger for autoimmune hepatitis in susceptible individuals / S. Vento, L. Guella, F. Mirandola [et al.] // Lancet. — 1995. — Vol. 346,
№ 8975. — P. 608–609.
320. Vergani, D. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group / D. Vergani, F. Alvarez, F. B. Bianchi [et al.] // J. Hepatol. — 2004. — Vol. 41, № 4. —
P. 677–683.
321. Vierling, J. M. Autoimmune hepatitis and antigen-specific T regulatory cells: when can we send in the regulators? / J. M. Vierling // Hepatology. — 2011. — Vol. 53,
№ 2ю — P. 385-388.
322. Vogel, A. Autoimmune hepatitis / A. Vogel, M. P. Manns // 1st edition - Bremen: UNI-MED Verlag AG. — 2010. — P. 112.
227
323.Volta, U. Gut-liver axis: an immune link between celiac disease and primary
biliary |
cirrhosis |
/ |
U. Volta, G. Caio, F. Tovoli, R. |
De Giorgio |
// |
Expert. Rev. |
|
Gastroenterol. Hepatol. — 2013. — Vol. 7, № 3. — P. 253-261. |
|
|
|
||||
324. |
Vreeburg, S. A. Major depressive disorder and hypothalamic-pituitary-adrenal |
||||||
axis activity: results from a large cohort study / S. A. Vreeburg, W. J. Hoogendijk, |
J. |
||||||
van Pelt [et al.] // Arch. Gen. Psychiatry. — 2009. Vol. 66, № 6. — P. 617-626. |
|
||||||
325. |
Wang, |
L. |
Correlation study of estrogen |
receptor |
with peripheral |
||
blood cytokines and |
serum markers in primary biliary cirrhosis |
patients / |
L. |
||||
Wang, Q.M. Li, |
H. H. Du [et al.] // Zhonghua Gan Zang Bing Za Zhi. — 2012. — Vol. |
||||||
20, № 5. — P. 336-339. |
|
|
|
|
|||
326.Wang, Q. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis / Q. Wang, C. Selmi, X. Zhou, [et al.] // J. Autoimmun. — 2013. — Vol. 41. — P. 140-145.
327.Washington, M. K. Autoimmune liver disease: overlap and outliers / M. K. Washington // Mod. Pathol. — 2007. — Vol. 1. — P. S15–30.
328.Watts, A.D. A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling' / A. D. Watts, N. H. Hunt, Y. Wanigasekara [et al.] // EMBO J. — 1999. — Vol. 18,
№ 8. — P. 2119-2126.
329. Weiler-Normann, C. Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis / C. Weiler-Normann, C. Schramm, A. Quaas [et al.] // J. Hepatol.
— 2013. — Vol. 58, № 3. — P. 529-534.
330. Weiler-Normann, C. Anxiety and depression in patients with autoimmune hepatitis / C. Weiler-Normann, I. Wahl, C. Wiegard1, C. Glaubke1 // J. Hepatol. — 2010. — Vol. 52. — P. 319–457.
331. Weiler-Normann, C. A case of difficultto-treat autoimmune hepatitis successfully managed by TNF-alpha blockade / C. Weiler-Normann, C. Wiegard, C. Schramm, A. W. Lohse // Am. J. Gastroenterol. — 2009. — Vol. 104, № 11. — P. 2877–2878.
228
332. Wilson, A. G. Genetics of tumour necrosis factor (TNF) in autoimmune liver diseases: red hot or red herring? / A. G. Wilson // J. Hepatol. — 1999. — Vol. 30, № 2.
— P. 331-333.
333.Wong, G. L. Health-related quality of life in Chinese patients with primary biliary cirrhosis / G. L. Wong, F. M. Law, V. W. Wong [et al.] // J. Gastroenterol. Hepatol. — 2008. — Vol. 23, № 4. — P. 592-598.
334.Wu, X. P. Impact of anxiety-depression symptoms on clinical recovery and serum TNF-alpha and IL-6 of patients with burns / X. P. Wu, D. Wang, Z. J. Song [et al.] // Sichuan. Da Xue Xue Bao Yi Xue Ban. — 2008. — Vol. 39, № 1. — P. 105-107.
335.Xiao, H. Diagnostic significance of autoantibodies in patients with primary biliary cirrhosis / H. Xiao, J. W. Chen, X. Xie [et al.] // Beijing Da Xue Xue Bao. —
2012. — Vol. 44, № 2. — P. 209-214.
336.Yamashiki, M. Analysis of serum cytokine levels in primary biliary cirrhosis patients and healthy adults / M. Yamashiki, Y. Kosaka, A. Nishimura [et al.] // J. Clin. Lab. Anal. — 1998. — Vol. 12, № 2. — P. 77-82.
337.Yasoshima, M. Increased expression of interleukin-6 and tumor necrosis factoralpha in pathologic biliary epithelial cells: in situ and culture study / M. Yasoshima, N. Kono, H. Sugawara // Lab. Invest. – 1998. – Vol. 78, № 1. – P. 89-100.
338.Yoshizawa, K. Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis / K. Yoshizawa, M. Ota, Y. Katsuyama [et al.] // J. Hepatol. — 2005. — № 42. — P. 578-584.
339.Younossi, Z. M. Cholestatic liver diseases and health-related quality of life / Z. M. Younossi, M. L. Kiwi, N. Boparai // Am. J. Gastroenterol. — 2000. — Vol. 95.
— P. 497-502.
340.Zhang, C. The regulatory effect of natural killer cells: do ―NK-reg cells‖ exist? /
C. Zhang, J. Zhang, Z. Tian // Cell. Mol. Immunol. — 2006. — Vol. 3. — P. 241–254. 341. Zhao, P. Low incidence of positive smooth muscle antibody and high incidence of isolated IgM elevation in Chinese patients with autoimmune hepatitis and primary biliary cirrhosis overlap syndrome: a retrospective study / P. Zhao, Y. Han // BMC
|
|
229 |
|
|
Gastroenterol. |
— |
2012. |
Режим |
доступа: |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264530
342. Zheng, S. J. Critical roles of TRAIL in hepatic cell death and hepatic inflammation / S. J. Zheng, P. Wang, G. Tsabary, Y. H. Chen // J. Clin. Invest. — 2004.
— Vol. 113, № 1. — P. 58-64.
343.Zimmermann, H.W. Interleukin8 is activated in patients with chronic liver disea ses and associated with hepatic macrophage accumulation in human liver fibrosis [Электронный доступ] / H.W. Zimmermann, S. Seidler, N. Gassler [et al.] // PLoS One. — 2011. — Vol. 6, № 6. Режим доступа: http://www.plosone.org
344.Zuberi, B. F. Correlation of quality of life in patients of cirrhosis of liver with etiology and disease severity using disease-specific quality of life questionnaire / B. F. Zuberi, A. R. Memon, S. Afsar [et al.] // J. Ayub. Med. Coll. Abbottabad. — 2007. —
Vol. 19, № 2. — P. 7-11.
345.Zung, W. W. A self-rat ing depression scale / W. W. Zung // Arch. Gen. Psychiatry. — 1965. — Vol. 12. — P. 63-70.